Moore Capital Management, LP Kura Oncology, Inc. Transaction History
Moore Capital Management, LP
- $5.98 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding KURA
# of Institutions
172Shares Held
80.9MCall Options Held
914KPut Options Held
120K-
Suvretta Capital Management, LLC New York, NY7.07MShares$148 Million6.46% of portfolio
-
Black Rock Inc. New York, NY6.9MShares$145 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$122 Million3.53% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$113 Million2.38% of portfolio
-
Bvf Inc San Francisco, CA4.79MShares$100 Million3.06% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.4B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...